Filing Details
- Accession Number:
- 0001415889-24-011406
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-04-23 21:35:31
- Reporting Period:
- 2024-04-20
- Accepted Time:
- 2024-04-23 21:35:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1604821 | Natera Inc. | NTRA | Services-Medical Laboratories (8071) | 010894487 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1857843 | Daniel Rabinowitz | C/O Natera, Inc. 13011 Mccallen Pass Building A Suite 100 Austin TX 78753 | Sec. And Chief Legal Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-04-20 | 856 | $0.00 | 205,695 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-04-21 | 644 | $0.00 | 206,339 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-04-23 | 787 | $91.38 | 205,552 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Unit | Disposition | 2024-04-20 | 856 | $0.00 | 856 | $0.00 |
| Common Stock | Restricted Stock Unit | Disposition | 2024-04-21 | 644 | $0.00 | 644 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 5,992 | No | 4 | M | Direct | ||
| 1,932 | No | 4 | M | Direct |
Footnotes
- Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
- The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 22, 2021 and January 28, 2022.
- The RSUs vest over four years. 25% of the RSUs vested on January 20, 2023 and the remaining shares vest in 12 equal quarterly installments thereafter.
- The RSUs vest over four years. 25% of the RSUs vested on January 21, 2022 and the remaining shares vest in 12 equal quarterly installments thereafter.
Billionaire Hedge Funds
